{"nctId":"NCT00297882","briefTitle":"Artemisinin-Based Combination Therapy: Clinical Trials in Cameroon","startDateStruct":{"date":"2006-07"},"conditions":["Malaria"],"count":816,"armGroups":[{"label":"1 Artemether-Lumefantrine (AL)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 1. Artemether-Lumefantrine (AL)"]},{"label":"2 Amodiaquine-Artesunate (AQ-AS)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 2. Amodiaquine-Artesunate (AQ-AS)"]}],"interventions":[{"name":"1. Artemether-Lumefantrine (AL)","otherNames":["CoArtem"]},{"name":"2. Amodiaquine-Artesunate (AQ-AS)","otherNames":["Arsucam"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria:\n\n* children aged 6-120 months;\n* axillary temperature ≥ 37.5°C and/or history of fever within past 24 hours;\n* P. falciparum asexual parasitemia between 1000 and 100000/µl;\n* ability to attend follow-up visits.\n\nExclusion criteria:\n\n* co-infections;\n* underlying chronic disease;\n* severe malaria as indicated by hyperparasitemia, severe anemia (PCV 15%, Hb 5g/ml), respiratory distress, inability to drink, persistent vomiting in past 24 hours;\n* recent history of multiple convulsions;\n* jaundice;\n* the inability to stand or sit;\n* history of allergy to study drugs.","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Months","maximumAge":"120 Months","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Cure Rate on Day 28","description":"To evaluate the safety and antimalarial efficacy of two drug combinations: Artemether-Lumefantrine (AL) and Amodiaquine-Artesunate (AQ - AS) in Camaroonian patients in Mutengene, Bangolan and Garoua","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"197","spread":null},{"groupId":"OG001","value":"603","spread":null}]}]}]},{"type":"SECONDARY","title":"Cure Rate Day 14","description":"To evaluate antimalarial efficacy of AL and AQ-AS on day 14 post-treatment","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"192","spread":null},{"groupId":"OG001","value":"563","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":204},"commonTop":["Leucopenia","Anorexia","Lymphopenia","Abdominal pain","Diarrhea"]}}}